CD79A Antibodies

Santa Cruz Biotechnology provides a broad selection of CD79A monoclonal antibodies for researchers studying B cell biology. CD79A monoclonal antibodies are highly effective in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD79A, also known as Ig-alpha, is a critical component of the B cell receptor complex, playing a vital role in B cell activation and signaling. CD79A is essential for the development and function of B lymphocytes, influencing immune responses and antibody production. Understanding CD79A function provides valuable insights into various immunological disorders. CD79A research contributes significantly to the development of targeted therapeutic approaches. Investigating CD79A expression patterns helps identify specific B cell populations and their roles in immune responses. CD79A analysis aids in understanding B cell development stages and potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance B cell research and develop innovative therapeutic strategies for immune-related conditions.